The Mechanisms, Research Status, and Future Prospects of m6A Modification in Breast Cancer

Documenti analoghi

• Characterization of Immune Landscape Based on Homologous Recombination Deficiency Associated Signatures and Identification of Knockdown of ERCC6L to Promote Radiosensitivity in Breast Cancer
  di: Jiahao Li, et al.
  Pubblicazione: (2025)
• Characterization of the m6A/m1A/m5C/m7G‐related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA‐seq and bulk RNA‐seq data
  di: Longkun Yang, et al.
  Pubblicazione: (2024)
• Long Noncoding RNAs (LncRNA‐4.2, LncRNA‐4.3) and Their Correlation With Hypoxia‐Related Biomarkers in Breast Cancer
  di: Hatem M. Hadeed, et al.
  Pubblicazione: (2025)
• YTHDF3 Promotes N6‐Methyladenosine Modification of SOCS1 to Inhibit JAK1/STAT3 Pathway in the Pathogenesis of Preeclampsia
  di: Shuang Sui, et al.
  Pubblicazione: (2025)
• Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1
  di: Zhihao Wen, et al.
  Pubblicazione: (2024)